|
Strong Buy (3.63 out of 4)
64th percentile
|
Strong Buy (3.63 out of 4)
64th percentile
|
|
|
SLIDESHOW: Top 10 Analyst Rated Healthcare Stocks
By ETF Channel Staff, updated Saturday, May 11, 3:09 PM
#10: Insulet Corp (NASDAQ:PODD) Insulet is primarily engaged in the development, manufacture and sale of its proprietary Omnipod® System, a continuous insulin delivery system for people with insulin-dependent diabetes. The Omnipod System includes: the Omnipod Insulin Management System, the Omnipod DASH® Insulin Management System (Omnipod DASH), its digital mobile Omnipod platform and the Omnipod® 5 Automated Insulin Delivery System. The Omnipod System features two devices: the Omnipod device; and the Personal Diabetes Manager. Omnipod DASH features a Bluetooth enabled Pod and PDM with a color touch screen user interface supported by smartphone connectivity and nightly automatic data uploads. Open the PODD Page at ETF Channel »
Company Name: |
Insulet Corp |
Website: |
www.insulet.com |
Sector: |
Medical Instruments & Supplies |
Number of ETFs Holding PODD: |
91 |
Total Market Value Held by ETFs: |
$2.20B |
Total Market Capitalization: |
$12.28B |
% of Market Cap. Held by ETFs: |
17.91% |
|
Open the ETF Channel PODD Page (in a new window) »
|
|
|